506 studies found for:    Open Studies | "Pulmonary Disease, Chronic Obstructive"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pulmonary Disease, Chronic Obstructive"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Chronic Obstructive Lung Disease;   Chronic Obstructive Airway Disease;   Chronic Bronchitis;   Emphysema
Interventions: Behavioral: Mindfulness-based cognitive therapy;   Behavioral: Pulmonary rehabilitation
2 Recruiting A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
3 Not yet recruiting Resveratrol In Overweight Mild To Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Conditions: Pulmonary Disease, Chronic Obstructive;   Overweight
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
4 Unknown  Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Traditional Chinese Medicine;   Drug: placebo chinese medicine
5 Unknown  Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China;   Other: usual care
6 Unknown  Timing of Dilation Tracheostomy in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Procedure: Percutaneous dilation tracheostomy
7 Not yet recruiting A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide;   Drug: Placebo
8 Recruiting Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4);   Drug: non-acetylated salicylate;   Dietary Supplement: High Fat Meal;   Drug: L-NMMA;   Dietary Supplement: Antioxidant Cocktail
9 Recruiting Long-term Physical Training in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Physical training
10 Recruiting Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Procedure: Spirometry
11 Unknown  Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Behavioural intervention;   Behavioral: Usual care group
12 Recruiting An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo;   Drug: PF-03715455
13 Not yet recruiting An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK2269557;   Drug: Placebo
14 Recruiting Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Losmapimod tablets;   Drug: Placebo tablets
15 Recruiting Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Conditions: COPD;   COPD Exacerbation;   Lung Diseases;   Respiratory Disorders;   Pulmonary Disease;   Chronic Obstructive Lung Diseases;   Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
16 Recruiting Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol;   Drug: Vilanterol
17 Recruiting A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
18 Recruiting Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: olodaterol;   Drug: tiotropium
19 Recruiting A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate (FF);   Drug: vilanterol (VI);   Drug: umeclidinium bromide (UMEC)
20 Recruiting A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Triple FF/UMEC/VI;   Drug: Placebo to match FF/UMEC/VI;   Drug: Budesonide/Formoterol;   Drug: Placebo to match Budesonide/Formoterol combination;   Drug: Albuterol/salbutamol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years